Company / Goodwill
Jazz Pharmaceuticals Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$1.8B
FY2025
5-year range
$1.7B / $1.8B
FY2021-FY2025
Trend
+6.6%
vs FY2024
Sector context
#17 of 75
Health Care
What the data says
Jazz Pharmaceuticals's goodwill of $1.8B is higher than 77% of companies in the Health Care sector (FY2025). Goodwill has fluctuated over the past 10 years, ranging from $894M in FY2016 to $1.8B in FY2025.
Based on SEC 10-K filings.
$1.8B in FY2025 with a 5-year CAGR of +13.8%. Top quartile in the Health Care sector.
Improved from $1.8B to $1.8B over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +2.6%
- 5-Year CAGR
- +13.8%
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 75This company $1.8B Sector average $4.0B
▼
-53.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +13.8%, indicating consistent growth.
- In FY2025, goodwill increased 6.6% year-over-year.
- Ranks #17 out of 75 companies in the Health Care sector.
- Lowest goodwill in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.8B | +6.6% |
| FY2024 | $1.7B | -2.1% |
| FY2023 | $1.8B | +3.6% |
| FY2022 | $1.7B | -7.4% |
| FY2021 | $1.8B | +90.7% |
| FY2020 | $958.3M | +4.2% |
| FY2019 | $920.0M | -0.8% |
| FY2018 | $927.6M | -2.1% |
| FY2017 | $947.5M | +6.0% |
| FY2016 | $893.8M | +36.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026